Evidence map›Paper›PMID 39896588›Full record

ArticlebioRxiv : the preprint server for biology2025

Diet gel-based oral drug delivery system for controlled dosing of small molecules for microglia depletion and inducible Cre recombination in mice.

Joel Jovanovic, Megan L Stone, Samantha R Dooyema, Yuankai K Tao, Sabine Fuhrmann, Edward M Levine

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Joel JovanovicVanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, United States.ORCID 0000-0002-9195-2239
Megan L StoneDepartment of Cell and Developmental Biology, Vanderbilt University, Nashville, TN, United States.ORCID 0000-0003-0883-8484
Samantha R DooyemaVanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, United States.
Yuankai K TaoVanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, United States.ORCID 0000-0002-6135-6241
Sabine FuhrmannVanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, United States.ORCID 0000-0002-2456-5490
Edward M LevineVanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, TN, United States.ORCID 0000-0003-1725-2805

Funding

Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI David J. Calkins · 1989 to 2026
$19.6M
Neurogenic potential of murine Müller glia following retinal injury and conditional inactivation of p27Kip1R21EY033473 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LEVINE, EDWARD M · 2022 to 2023
$476k
Regulation of the lens transcriptome and chromatin architecture by FOXE3R21EY033471 · NEI · MIAMI UNIVERSITY OXFORD · PI ROBINSON, MICHAEL L · 2022 to 2023
$397k
NEI NIH HHS P30 EY008126NEI NIH HHS R21 EY033471NEI NIH HHS R21 EY033473
6 · The paper itself

Abstract

Small molecules like PLX5622 for microglia depletion and Tamoxifen for inducible Cre recombination are commonly used in mouse research. Traditional application methods, such as chow or oral gavage and injections, have limitations, including uncontrolled dosage and risk of injury. To address this issue, we have developed an alternative oral drug delivery system using a gel-based rodent maintenance diet that allows for controlled consumption and adjustment of dosage and is suitable for water-insoluble small molecules. We tested DietGel

Indexed as

3RsCre recombinationDietGel® 93Mdrug delivery systemgel-based rodent dietmicrogliaMüller gliaPLX5622refinementscanning laser ophthalmoscopy (SLO)small moleculesTamoxifen

Identifiers

PMID39896588
PMCPMC11785137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.